XML 85 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]        
Net sales $ 46,778 $ 60,821 $ 147,053 $ 165,508
Cost of products sold 34,749 50,491 109,642 140,281
Gross profit 12,029 10,330 37,411 25,227
Operating expenses 8,223 8,026 24,688 22,564
Operating profit 3,806 2,304 12,723 2,663
Pension expense (41) (18) (122) (53)
Other income, net 161 210 384 756
Interest expense (411) (436) (1,213) (1,190)
Profit before income taxes 3,515 2,060 11,772 2,176
Income tax expense 982 962 3,894 1,911
Net earnings 2,533 1,098 7,878 265
Less: Net earnings attributable to the non-controlling interest 12 375 151 532
Net earnings (loss) attributable to Kewaunee Scientific Corporation $ 2,521 $ 723 $ 7,727 $ (267)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ 0.87 $ 0.26 $ 2.68 $ (0.09)
Diluted (in dollars per share) $ 0.85 $ 0.25 $ 2.64 $ (0.09)
Weighted average number of common shares outstanding        
Basic (in shares) 2,893 2,830 2,885 2,822
Diluted (in shares) 2,965 2,911 2,927 2,822